NE BUSINESS BUREAU
MUMBAI, NOV 14
Procter & Gamble Health Limited (formerly Merck Limited) on Friday announced that its Profit After Tax (PAT) rose to ₹59.3 crores for the quarter ended September 30, 2020, which was ₹35.8 crores in the year-ago period. The company has recorded total revenue of ₹264.0 crores during the reporting period, up 17.2% against year ago.
Milind Thatte, Managing Director, Procter & Gamble Health Limited said, “With the country still amid the pandemic, we remain focussed on protecting the health and safety of our employees and partners, ensuring uninterrupted supplies of our quality and affordable vitamins, minerals, supplements, and medicinal products for our patients and consumers, and on supporting communities and relief efforts.
“Despite tough market conditions, the Company has made a strong recovery in the first quarter delivering a double- digit growth driven by portfolio consumerisation, robust business continuity planning and a phased return-to-work initiative. We are very proud of our teams who have been quick and agile to adapt to the changing environment, embracing virtual mediums to ensure continued connect with HCPs and partners, and stepping up on consumer outreach efforts resulting in a positive brand recall across categories. With ‘SEHAT’ (meaning Health) – our Corporate Social Responsibility (CSR) initiative – the Company continues to step up as a #ForceForGood reaching out to vulnerable populations and supporting relief efforts through partner NGOs.”
